LA | |
---|---|
Post | - |
Pre | - |
M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1.3 | 0.4 | 35.8 | 18.9 | 26.8 | 301.6 | 111.0 | 21.5 | 0.6 | - | 517.9 |
1 | - | - | 0.6 | 0.5 | 0.3 | 22.6 | 11.5 | 1.1 | - | - | 36.7 |
LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
---|---|---|---|---|---|---|---|---|
Post | - | - | - | - | - | - | - | - |
Pre | - | - | - | - | - | - | - | - |
AME | |
---|---|
0 | 38.5 |
1 | 33.1 |
LOP1 | LOP2 | LOP3 | LOP4 | Total | |
---|---|---|---|---|---|
Post | - | - | - | - | - |
Pre | - | - | - | - | - |
central brain | |
---|---|
0 | 65.3 |
1 | 114.6 |
Number of post synapses: | 8805 |
Number of pre synapses: | 624 |
Number of output connections: | 1363 |
Coverage factor: | 1.5 |
Columnar completeness: | 0.85 |
Area completeness: | 0.91 |
Cell size (columns): | 55 |
Number of post synapses: | 0 |
Number of pre synapses: | 0 |
Number of output connections: | 0 |
Coverage factor: | 0 |
Columnar completeness: | 0 |
Area completeness: | 0 |
Cell size (columns): | 0 |
Number of post synapses: | 0 |
Number of pre synapses: | 0 |
Number of output connections: | 0 |
Coverage factor: | 0 |
Columnar completeness: | 0 |
Area completeness: | 0 |
Cell size (columns): | 0 |
instance | NT | total connections | connections /#aMe5 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | Mi15 (R) | ACh | 2,137 | 125.7 | 22.2% | 22.2% |
1 | Tm39 (R) | ACh | 528 | 31.1 | 5.5% | 27.7% |
2 | MeTu3c (R) | ACh | 516 | 30.4 | 5.4% | 33.0% |
3 | Mi10 (R) | ACh | 441 | 25.9 | 4.6% | 37.6% |
4 | aMe5 (R) | ACh | 348 | 20.5 | 3.6% | 41.2% |
5 | Mi9 (R) | Glu | 310 | 18.2 | 3.2% | 44.5% |
6 | Dm8b (R) | Glu | 262 | 15.4 | 2.7% | 47.2% |
7 | MeLo4 (R) | ACh | 260 | 15.3 | 2.7% | 49.9% |
8 | Tm29 (R) | Glu | 259 | 15.2 | 2.7% | 52.6% |
9 | MeTu3b (R) | ACh | 252 | 14.8 | 2.6% | 55.2% |
10 | Tm26 (R) | ACh | 245 | 14.4 | 2.5% | 57.7% |
11 | Cm31b (R) | GABA | 243 | 14.3 | 2.5% | 60.3% |
12 | Tm5c (R) | Glu | 237 | 13.9 | 2.5% | 62.7% |
13 | Tm5b (R) | ACh | 229 | 13.5 | 2.4% | 65.1% |
14 | Tm12 (R) | ACh | 144 | 8.5 | 1.5% | 66.6% |
15 | MeVPMe11 (L) | Glu | 107 | 6.3 | 1.1% | 67.7% |
16 | Cm34 (R) | Glu | 106 | 6.2 | 1.1% | 68.8% |
17 | aMe6b (R) | ACh | 92 | 5.4 | 1.0% | 69.8% |
18 | MeVP3 (R) | ACh | 90 | 5.3 | 0.9% | 70.7% |
19 | aMe2 (R) | Glu | 84 | 4.9 | 0.9% | 71.6% |
20 | aMe10 (L) | ACh | 83 | 4.9 | 0.9% | 72.4% |
21 | Cm11d (R) | ACh | 82 | 4.8 | 0.9% | 73.3% |
22 | HBeyelet (R) | His | 80 | 4.7 | 0.8% | 74.1% |
23 | Cm31a (R) | GABA | 74 | 4.4 | 0.8% | 74.9% |
24 | R8y (R) | His | 74 | 4.4 | 0.8% | 75.6% |
25 | Dm-DRA1 (R) | Glu | 70 | 4.1 | 0.7% | 76.4% |
26 | Cm7 (R) | Glu | 69 | 4.1 | 0.7% | 77.1% |
27 | Dm2 (R) | ACh | 59 | 3.5 | 0.6% | 77.7% |
28 | Mi16 (R) | GABA | 58 | 3.4 | 0.6% | 78.3% |
29 | TmY21 (R) | ACh | 58 | 3.4 | 0.6% | 78.9% |
30 | aMe10 (R) | ACh | 57 | 3.4 | 0.6% | 79.5% |
31 | Mi4 (R) | GABA | 57 | 3.4 | 0.6% | 80.1% |
32 | Dm9 (R) | Glu | 54 | 3.2 | 0.6% | 80.7% |
33 | MeVP12 (R) | ACh | 54 | 3.2 | 0.6% | 81.2% |
34 | Cm26 (R) | Glu | 53 | 3.1 | 0.6% | 81.8% |
35 | aMe6c (R) | Glu | 52 | 3.1 | 0.5% | 82.3% |
36 | aMe30 (R) | Glu | 48 | 2.8 | 0.5% | 82.8% |
37 | Cm20 (R) | GABA | 47 | 2.8 | 0.5% | 83.3% |
38 | MeLo3b (R) | ACh | 46 | 2.7 | 0.5% | 83.8% |
39 | Tm5a (R) | ACh | 44 | 2.6 | 0.5% | 84.2% |
40 | MeVPMe6 (L) | Glu | 42 | 2.5 | 0.4% | 84.7% |
41 | Tm3 (R) | ACh | 38 | 2.2 | 0.4% | 85.1% |
42 | aMe12 (R) | ACh | 36 | 2.1 | 0.4% | 85.4% |
43 | LA_ME_unclear (R) | ACh | 33 | 1.9 | 0.3% | 85.8% |
44 | Cm2 (R) | ACh | 32 | 1.9 | 0.3% | 86.1% |
45 | MeVC2 (L) | ACh | 32 | 1.9 | 0.3% | 86.4% |
46 | Cm1 (R) | ACh | 30 | 1.8 | 0.3% | 86.7% |
47 | MeVPMe3 (L) | Glu | 30 | 1.8 | 0.3% | 87.1% |
48 | Cm4 (R) | Glu | 29 | 1.7 | 0.3% | 87.4% |
49 | Cm11b (R) | ACh | 26 | 1.5 | 0.3% | 87.6% |
50 | Cm22 (R) | GABA | 26 | 1.5 | 0.3% | 87.9% |
51 | Cm6 (R) | GABA | 26 | 1.5 | 0.3% | 88.2% |
52 | Dm8a (R) | Glu | 26 | 1.5 | 0.3% | 88.4% |
53 | OA-AL2i3 (R) | OA | 26 | 1.5 | 0.3% | 88.7% |
54 | Y14 (R) | Glu | 26 | 1.5 | 0.3% | 89.0% |
55 | aMe22 (R) | Glu | 25 | 1.5 | 0.3% | 89.2% |
56 | L5 (R) | ACh | 25 | 1.5 | 0.3% | 89.5% |
57 | MeLo1 (R) | ACh | 24 | 1.4 | 0.2% | 89.7% |
58 | MeVPMe7 (L) | Glu | 24 | 1.4 | 0.2% | 90.0% |
59 | R7_unclear (R) | His | 24 | 1.4 | 0.2% | 90.2% |
60 | R8_unclear (R) | His | 23 | 1.4 | 0.2% | 90.5% |
61 | Cm17 (R) | GABA | 22 | 1.3 | 0.2% | 90.7% |
62 | LT58 (R) | Glu | 22 | 1.3 | 0.2% | 90.9% |
63 | MeTu3a (R) | ACh | 22 | 1.3 | 0.2% | 91.2% |
64 | MeVC10 (L) | ACh | 21 | 1.2 | 0.2% | 91.4% |
65 | Tm30 (R) | GABA | 21 | 1.2 | 0.2% | 91.6% |
66 | Cm11a (R) | ACh | 19 | 1.1 | 0.2% | 91.8% |
67 | Cm21 (R) | GABA | 19 | 1.1 | 0.2% | 92.0% |
68 | Dm-DRA2 (R) | Glu | 18 | 1.1 | 0.2% | 92.2% |
69 | MeVP7 (R) | ACh | 18 | 1.1 | 0.2% | 92.4% |
70 | Tm20 (R) | ACh | 18 | 1.1 | 0.2% | 92.6% |
instance | NT | total connections | connections /#aMe5 (R) | % | % cumu. | |
---|---|---|---|---|---|---|
0 | aMe4 (R) | ACh | 496 | 29.2 | 11.8% | 11.8% |
1 | aMe5 (R) | ACh | 348 | 20.5 | 8.3% | 20.1% |
2 | MeVPaMe2 (L) | Glu | 273 | 16.1 | 6.5% | 26.6% |
3 | aMe10 (R) | ACh | 245 | 14.4 | 5.8% | 32.5% |
4 | MeVPaMe2 (R) | Glu | 212 | 12.5 | 5.1% | 37.5% |
5 | aMe2 (R) | Glu | 190 | 11.2 | 4.5% | 42.1% |
6 | aMe1 (R) | GABA | 185 | 10.9 | 4.4% | 46.5% |
7 | MeVPMe12 (R) | ACh | 172 | 10.1 | 4.1% | 50.6% |
8 | Tm30 (R) | GABA | 126 | 7.4 | 3.0% | 53.6% |
9 | MeLo3b (R) | ACh | 109 | 6.4 | 2.6% | 56.2% |
10 | aMe6b (R) | ACh | 99 | 5.8 | 2.4% | 58.5% |
11 | aMe23 (R) | unclear | 75 | 4.4 | 1.8% | 60.3% |
12 | MeVP12 (R) | ACh | 74 | 4.4 | 1.8% | 62.1% |
13 | MeVP14 (R) | ACh | 73 | 4.3 | 1.7% | 63.8% |
14 | aMe24 (R) | unclear | 63 | 3.7 | 1.5% | 65.3% |
15 | MeVPMe3 (R) | Glu | 62 | 3.6 | 1.5% | 66.8% |
16 | Cm21 (R) | GABA | 57 | 3.4 | 1.4% | 68.2% |
17 | aMe15 (R) | unclear | 51 | 3.0 | 1.2% | 69.4% |
18 | Cm35 (R) | GABA | 51 | 3.0 | 1.2% | 70.6% |
19 | Cm8 (R) | GABA | 48 | 2.8 | 1.1% | 71.7% |
20 | Tm31 (R) | Glu | 44 | 2.6 | 1.0% | 72.8% |
21 | MeVPMe4 (R) | Glu | 40 | 2.4 | 1.0% | 73.7% |
22 | Cm7 (R) | Glu | 39 | 2.3 | 0.9% | 74.7% |
23 | Tm38 (R) | ACh | 39 | 2.3 | 0.9% | 75.6% |
24 | aMe17b (R) | GABA | 36 | 2.1 | 0.9% | 76.5% |
25 | MeTu3c (R) | ACh | 35 | 2.1 | 0.8% | 77.3% |
26 | Cm15 (R) | GABA | 32 | 1.9 | 0.8% | 78.1% |
27 | Mi15 (R) | ACh | 32 | 1.9 | 0.8% | 78.8% |
28 | MeVPMe12 (L) | ACh | 30 | 1.8 | 0.7% | 79.5% |
29 | Tm26 (R) | ACh | 25 | 1.5 | 0.6% | 80.1% |
30 | MeVPMe11 (L) | Glu | 24 | 1.4 | 0.6% | 80.7% |
31 | l-LNv (R) | unclear | 23 | 1.4 | 0.5% | 81.3% |
32 | MeVP5 (R) | unclear | 23 | 1.4 | 0.5% | 81.8% |
33 | Tm39 (R) | ACh | 23 | 1.4 | 0.5% | 82.4% |
34 | aMe25 (R) | unclear | 19 | 1.1 | 0.5% | 82.8% |
35 | SLP250 (R) | unclear | 19 | 1.1 | 0.5% | 83.3% |
36 | CL083 (R) | unclear | 18 | 1.1 | 0.4% | 83.7% |
37 | Tm29 (R) | Glu | 18 | 1.1 | 0.4% | 84.1% |
38 | aMe26 (R) | ACh | 17 | 1.0 | 0.4% | 84.5% |